Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ANG LIFESCIENCES INDIA   ACTAVIS
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-23
ACTAVIS
Dec-18
ANG LIFESCIENCES INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs27616,126-   
Low Rs7210,818-   
Sales per share (Unadj.) Rs168.43,955.8-  
Earnings per share (Unadj.) Rs-0.2-1,274.2-  
Cash flow per share (Unadj.) Rs7.0416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs66.016,315.7-  
Shares outstanding (eoy) m13.06332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.03.4 30.3%   
Avg P/E ratio x-867.2-10.6 8,202.2%  
P/CF ratio (eoy) x25.032.3 77.3%  
Price / Book Value ratio x2.60.8 319.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,2724,480,758 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2400-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m2,1991,315,689 0.2%  
Other income Rs m9725,160 0.4%   
Total revenues Rs m2,2961,340,849 0.2%   
Gross profit Rs m14734,478 0.4%  
Depreciation Rs m94562,428 0.0%   
Interest Rs m12575,923 0.2%   
Profit before tax Rs m26-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m29-7,334 -0.4%   
Profit after tax Rs m-3-423,784 0.0%  
Gross profit margin %6.72.6 255.7%  
Effective tax rate %110.01.3 8,679.1%   
Net profit margin %-0.1-32.2 0.4%  
BALANCE SHEET DATA
Current assets Rs m1,852539,627 0.3%   
Current liabilities Rs m1,623477,372 0.3%   
Net working cap to sales %10.44.7 220.2%  
Current ratio x1.11.1 101.0%  
Inventory Days Days120 4.6%  
Debtors Days Days1,38066 2,081.5%  
Net fixed assets Rs m887148,929 0.6%   
Share capital Rs m1310-   
"Free" reserves Rs m7320-   
Net worth Rs m8625,426,601 0.0%   
Long term debt Rs m2051,910,903 0.0%   
Total assets Rs m2,7568,483,012 0.0%  
Interest coverage x1.2-6.6 -18.3%   
Debt to equity ratio x0.20.4 67.6%  
Sales to assets ratio x0.80.2 514.5%   
Return on assets %4.4-4.1 -108.1%  
Return on equity %-0.3-7.8 3.9%  
Return on capital %14.2-4.8 -292.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m320-   
CASH FLOW
From Operations Rs m264470,046 0.1%  
From Investments Rs m-93258,229 -0.0%  
From Financial Activity Rs m-171-806,740 0.0%  
Net Cashflow Rs m0-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ANG LIFESCIENCES INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ANG LIFESCIENCES INDIA With: VIVO BIO TECH  ORTIN LABS   KABRA DRUGS  RPG LIFE SCIENCES  VALIANT LABORATORIES LTD.  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.